Dr. Atul Bhardwaj, MD

Dr. Bhardwaj practices at WellSpan Good Samaritan Hospital in Lebanon, Pennsylvania, part of WellSpan Health.

Dr. Bhardwaj's NPI, 1477746170, was assigned on August 26, 2007. Dr. Bhardwaj holds Pennsylvania license MD434752.

Dr. Bhardwaj's primary practice is WellSpan Good Samaritan Hospital, at 252 South 4th Street, Lebanon, PA 17042 in Lebanon County. The practice phone is (717) 270-7500.

Dr. Bhardwaj's primary practice is WellSpan Good Samaritan Hospital in Lebanon, Pennsylvania, part of WellSpan Health. Dr. Bhardwaj is also affiliated with WellSpan Ephrata Community Hospital. The medical group on file is WellSpan Digestive Health. Dmand AI also links Dr. Bhardwaj to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhardwaj practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bhardwaj's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bhardwaj is licensed in Pennsylvania.

CMS data shows 502 Medicare services from Dr. Bhardwaj across 10 procedure codes in 2024, for 353 Medicare patients. Medicare paid $52,971 for them.

CMS counts 353 Medicare patients who saw Dr. Bhardwaj in 2024. The largest group is 65 to 74, with 200 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bhardwaj's median patient age at 70, with 55% women.

In 2024, Dr. Bhardwaj wrote 902 Medicare Part D claims for 202 patients. 85% of them were for generic drugs. CMS names the drug for 739 of them, across 17 drugs with 11 or more claims each, at $223,052 in total drug cost. In 2023, CMS named 721 claims across 15 drugs.

Dr. Bhardwaj accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 72 procedures of colonoscopy by Dr. Bhardwaj, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 32 papers to Dr. Bhardwaj, published from 2011 to 2023. 2023 was the busiest year, with 4. The most frequent topics are Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors and Drug Design. Dr. Bhardwaj has published most often in Bioorg Med Chem Lett. Dr. Bhardwaj's most frequent co-authors are Jatinder Kaur, MD, Thomas J. McGarrity, MD and Jackson Mittlesteadt, DO.

CMS Open Payments shows 528 general payments to Dr. Bhardwaj from 38 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $3,198. It also lists 1 research payment totaling $16 in 2017.